Stay updated on Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now indicates the study is not recruiting participants, clarifying its current status. It also adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with a revision tag (v3.6.0).
    Difference
    0.5%
    Check dated 2026-06-12T13:45:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5 instead of v3.5.4. This indicates a small version update to the site's template or code.
    Difference
    0.1%
    Check dated 2026-06-05T09:24:09.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page. This indicates a minor internal update to the entry without altering study details or displayed information.
    Difference
    0.1%
    Check dated 2026-05-14T23:03:28.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's revision history for this study record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-04-30T15:37:47.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:57:32.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision metadata updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:12.000Z thumbnail image

Stay in the know with updates to Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.